Summary & Overview
CPT 20552: Trigger Point Injection, 1–2 Muscles
CPT 20552 covers injections to one or two muscles targeting single or multiple trigger points, a common intervention in managing myofascial and musculoskeletal pain. Nationally, this code is relevant across outpatient physical medicine and rehabilitation practices and is frequently billed in office-based settings. It matters for providers, payers, and policy stakeholders because it intersects clinical pain management, conservative treatment pathways, and outpatient procedural billing.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise review of coverage considerations and typical claims context under those payers, as well as common clinical indications tied to trigger point injections.
Readers will learn the clinical scope and billing context of CPT 20552, how it relates to common outpatient service lines, and practical coding neighbors that are frequently billed in the same encounter. The piece outlines typical site of service and service type, summarizes associated clinical scenarios, and highlights related CPT codes and commonly paired evaluation/therapy services. Data gaps are noted where applicable. This summary aims to inform coding accuracy, administrative workflows, and payer discussions without making clinical or reimbursement recommendations.
CPT Code Overview
CPT 20552 describes injection(s) to single or multiple trigger point(s) involving 1 or 2 muscle(s). This procedure is used in the management of myofascial pain and related musculoskeletal conditions. It falls under the Physical Medicine & Rehabilitation service type and is commonly performed in an office setting (POS 11).
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to a Physical Medicine & Rehabilitation outpatient office (POS 11) with focal myofascial pain of the neck and upper back following an exacerbation of chronic cervicalgia. After history and focused musculoskeletal exam, the clinician identifies one or two active trigger points in the trapezius and levator scapulae muscles. The patient undergoes a trigger point injection procedure during the same visit using local anesthetic and/or corticosteroid as appropriate. The encounter may be billed with CPT 20552 for injection(s) to one or two muscles; documentation includes location of trigger points, number of muscles treated, informed consent, medications used, and post-procedure instructions. Typical workflow: check-in and medication reconciliation, focused exam and consent, procedure room preparation, performance of 20552, brief observation, and discharge with follow-up plan.
Coding Specifications
-
Common Modifiers
-
50- Bilateral ProcedureUsed when the same procedure (
20552) is performed bilaterally during the same encounter and payer rules allow reporting a bilateral modifier. Documentation must support bilateral treatment. -
59- Distinct Procedural ServiceUsed when
20552is performed at a separate anatomic site or on a different muscle group and the service is not typically bundled with other services on the same day. Documentation must support the distinctness of the procedure. -
Associated Provider Taxonomies and Specialties
| Taxonomy Code | Specialty |
|---|---|
208100000X | Physical Medicine & Rehabilitation Physician |
207XS0117X | Sports Medicine Physician |
207R00000X | Internal Medicine Physician |
Related Diagnoses
-
M79.7- FibromyalgiaFibromyalgia can present with widespread myofascial pain and tender points; trigger point injections like
20552may be used for focal symptomatic relief of prominent trigger points. -
M54.5- Low back painLow back pain may have myofascial components with discrete trigger points in paraspinal or gluteal muscles;
20552applies when one or two muscles with trigger points are injected. -
M79.1- MyalgiaGeneralized or localized muscle pain (myalgia) can produce identified trigger points suitable for injection with
20552when limited to one or two muscles. -
M25.50- Pain in unspecified jointJoint pain may coexist with adjacent myofascial trigger points;
20552is relevant when treating trigger points in nearby muscles contributing to the pain. -
M54.2- CervicalgiaNeck pain (cervicalgia) often involves trigger points in cervical and shoulder girdle muscles;
20552is used when one or two muscles with trigger points are injected to address focal cervical-related myofascial pain.
Related CPT Codes
| CPT Code | Description | Relationship to 20552 |
|---|---|---|
20553 | Injection(s); single or multiple trigger point(s), 3 or more muscles | Alternative when three or more muscles are treated instead of one or two; choose 20553 rather than 20552 when applicable. Commonly used as the next-level code for more extensive trigger point treatment. |
20610 | Arthrocentesis, aspiration and/or injection into a major joint or bursa | Different anatomic target (joint or bursa) and may be performed in the same visit for concurrent joint pathology; not billed in place of trigger point injections. |
99213 | Established patient office or other outpatient visit, level 3 | Evaluation and management code for the visit; may be reported with 20552 when documentation supports separate E/M services per payer rules. |
97110 | Therapeutic exercises to develop strength and endurance, range of motion and flexibility | Rehabilitative therapy commonly used in conjunction with trigger point injections as part of a conservative treatment plan; may be billed on the same day if documentation supports distinct therapy services. |
National Reimbursement Benchmarks
Medicare mean allowed rate for CPT 20552 is $53.33, which is lower than the BUCA (average commercial) mean of $65.95. The gap between Medicare and the average commercial benchmark represented by BUCA is $12.62 in mean allowed rate.
Rate dispersion varies notably across payers. UnitedHealth Group exhibits the widest interquartile range (P75−P25 = $50.33), followed by Cigna (P75−P25 = $44.50). The tightest distributions are seen with Medicare (P75−P25 = $5.00) and Aetna (P75−P25 = $27.67). The table and chart below present the full payer breakdown of mean rates and percentiles.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.